Antimicrobial therapies for Q fever

References

• McQuiston JH, Childs JE. Q fever in humans and animals in the United States. Vector Borne Zoonotic Dis. 2(3), 179–191 (2002).
   PubMed Web of Science ®Google Scholar
• Hatchette T, Campbell N, Hudson R, Raoult D, Marrie TJ. Natural history of Q fever in goats. Vector Borne Zoonotic Dis. 3(1), 11–15 (2003).
   PubMed Web of Science ®Google Scholar
• van der Hoek W, Dijkstra F, Schimmer B et al. Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill. 15(12), pii: 19520 (2010).
   Google Scholar
• Graham JG, MacDonald LJ, Hussain SK, Sharma UM, Kurten RC, Voth DE. Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages. Cell. Microbiol. 15(6), 1012–1025 (2013).
   PubMed Web of Science ®Google Scholar
• Voth DE, Heinzen RA. Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii. Cell. Microbiol. 9(4), 829–840 (2007).
   PubMed Web of Science ®Google Scholar
• Benenson AS, Tigertt WD. Studies on Q fever in man. Trans. Assoc. Am. Physicians 69, 98–104 (1956).
   PubMedGoogle Scholar
• Dupuis G, Petite J, Peter O, Vouilloz M. An important outbreak of human Q fever in a Swiss Alpine valley. Int. J. Epidemiol. 16(2), 282–287 (1987).
   PubMed Web of Science ®Google Scholar
• Maurin M, Raoult D. Q fever. Clin. Microbiol. Rev. 12(4), 518–553 (1999).
   PubMed Web of Science ®Google Scholar
• Clark WH, Lennette EH. Treatment of Q fever with antibiotics. Ann. NY Acad. Sci. 55(6), 1004–1018 (1952).
   PubMed Web of Science ®Google Scholar
• Marrie TJ. Acute Q fever. In: Q Fever vol. 1. The disease. Marrie TJ ( Ed.). CRC Press, Boca Raton, FL, 125–160 (1990).
   Google Scholar
• Botelho-Nevers E, Fournier PE, Richet H et al. Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome. Eur. J. Clin. Microbiol. Infect. Dis. 26(9), 635–640 (2007).
   PubMed Web of Science ®Google Scholar
• Fournier PE, Casalta JP, Piquet P, Tournigand P, Branchereau A, Raoult D. Coxiella burnetii infection of aneurysms or vascular grafts: report of seven cases and review. Clin. Infect. Dis. 26(1), 116–121 (1998).
   PubMed Web of Science ®Google Scholar
• Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D. Risks factors and prevention of Q fever endocarditis. Clin. Infect. Dis. 33(3), 312–316 (2001).
   PubMed Web of Science ®Google Scholar
• Kampschreur LM, Dekker S, Hagenaars JC et al. Identification of risk factors for chronic Q fever, the Netherlands. Emerg. Infect. Dis. 18(4), 563–570 (2012).
   PubMed Web of Science ®Google Scholar
• Ellis ME, Smith CC, Moffat MA. Chronic or fatal Q-fever infection: a review of 16 patients seen in North-East Scotland (1967–80). Q. J. Med. 52(205), 54–66 (1983).
   PubMedGoogle Scholar
• Jover-Diaz F, Robert-Gates J, Andreu-Gimenez L, Merino-Sanchez J. Q fever during pregnancy: an emerging cause of prematurity and abortion. Infect. Dis. Obstetr. Gynecol. 9(1), 47–49 (2001).
   PubMedGoogle Scholar
• Langley JM, Marrie TJ, Leblanc JC, Almudevar A, Resch L, Raoult D. Coxiella burnetii seropositivity in parturient women is associated with adverse pregnancy outcomes. Am. J. Obstetr. Gynecol. 189(1), 228–232 (2003).
   PubMed Web of Science ®Google Scholar
• Stein A, Raoult D. Q fever during pregnancy: a public health problem in southern France. Clin. Infect. Dis. 27(3), 592–596 (1998).
   PubMed Web of Science ®Google Scholar
• Raoult D, Fenollar F, Stein A. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch. Intern. Med. 162(6), 701–704 (2002).
   PubMedGoogle Scholar
• Raoult D, Stein A. Q fever during pregnancy--a risk for women, fetuses, and obstetricians. N. Engl. J. Med. 330(5), 371 (1994).
   Web of Science ®Google Scholar
• Schneeberger PM, Hermans MH, van Hannen EJ, Schellekens JJ, Leenders AC, Wever PC. Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clin. Vaccine Immunol. 17(2), 286–290 (2010).
   PubMedGoogle Scholar
• Stoker MG, Fiset P. Phase variation of the Nine Mile and other strains of Rickettsia burneti. Can. J. Microbiol. 2(3), 310–321 (1956).
   PubMed Web of Science ®Google Scholar
• CDC. Diagnosis and management of Q Fever – United States, 2013: recommendations from CDC and the Q Fever working group. MMWR Morb. Mortal. Wkly Rep. 62(RR03), 1–23 (2013).
   PubMed Web of Science ®Google Scholar
• Teunis PF, Schimmer B, Notermans DW et al. Time-course of antibody responses against Coxiella burnetii following acute Q fever. Epidemiol. Infect. 141(1), 62–73 (2013).
   PubMed Web of Science ®Google Scholar
• Wegdam-Blans MC, Kampschreur LM, Delsing CE et al. Chronic Q fever: review of the literature and a proposal of new diagnostic criteria. J. Infect. 64(3), 247–259 (2012).
   PubMed Web of Science ®Google Scholar
• Gikas A, Kofteridis DP, Manios A, Pediaditis J, Tselentis Y. Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob. Agents chemother. 45(12), 3644–3646 (2001).
   PubMed Web of Science ®Google Scholar
• Sobradillo V, Zalacain R, Capelastegui A, Uresandi F, Corral J. Antibiotic treatment in pneumonia due to Q fever. Thorax 47(4), 276–278 (1992).
   PubMed Web of Science ®Google Scholar
• Million M, Thuny F, Richet H, Raoult D. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect. Dis. 10(8), 527–535 (2010).
   PubMed Web of Science ®Google Scholar
• Levy PY, Drancourt M, Etienne J et al. Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis. Antimicrob. Agents chemother. 35(3), 533–537 (1991).
   PubMed Web of Science ®Google Scholar
• Lam C, Mathison GE. Effect of low intraphagolysosomal pH on antimicrobial activity of antibiotics against ingested staphylococci. J. Med. Microbiol. 16(3), 309–316 (1983).
   PubMed Web of Science ®Google Scholar
• Raoult D, Drancourt M, Vestris G. Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells. Antimicrob. Agents Chemother. 34(8), 1512–1514 (1990).
   PubMed Web of Science ®Google Scholar
• Maurin M, Benoliel AM, Bongrand P, Raoult D. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. J. Infect. Dis. 166(5), 1097–1102 (1992).
   PubMed Web of Science ®Google Scholar
• Raoult D, Houpikian P, Tissot Dupont H, Riss JM, Arditi-Djiane J, Brouqui P. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch. Intern. Med. 159(2), 167–173 (1999).
   PubMedGoogle Scholar
• Beringer PM, Owens H, Nguyen A, Benitez D, Rao A, D'Argenio DZ. Pharmacokinetics of doxycycline in adults with cystic fibrosis. Antimicrob. Agents Chemother. 56(1), 70–74 (2012).
   PubMed Web of Science ®Google Scholar
• Neuvonen PJ, Gothoni G, Hackman R, Bjorksten K. Interference of iron with the absorption of tetracyclines in man. Br. Med. J. 4(5734), 532–534 (1970).
   PubMed Web of Science ®Google Scholar
• Lecaillet A, Mallet MN, Raoult D, Rolain JM. Therapeutic impact of the correlation of doxycycline serum concentrations and the decline of phase I antibodies in Q fever endocarditis. J. Antimicrob. Chemother. 63(4), 771–774 (2009).
   PubMed Web of Science ®Google Scholar
• Drucker AM, Rosen CF. Drug-induced photosensitivity: culprit drugs, management and prevention. Drug saf. 34(10), 821–837 (2011).
   PubMed Web of Science ®Google Scholar
• Tehrani R, Ostrowski RA, Hariman R, Jay WM. Ocular toxicity of hydroxychloroquine. Semin. Ophthalmol. 23(3), 201–209 (2008).
   PubMedGoogle Scholar
• Maltezou HC, Constantopoulou I, Kallergi C et al. Q fever in children in Greece. Am. J. Trop. Med. Hyg. 70(5), 540–544 (2004).
   PubMed Web of Science ®Google Scholar
• Roest HJ, van Gelderen B, Dinkla A et al. Q fever in pregnant goats: pathogenesis and excretion of Coxiella burnetii. PLoS ONE 7(11), e48949 (2012).
   Web of Science ®Google Scholar
• Boden K, Brueckmann A, Wagner-Wiening C et al. Maternofetal consequences of Coxiella burnetii infection in pregnancy: a case series of two outbreaks. BMC Infect. Dis. 12, 359 (2012).
   PubMed Web of Science ®Google Scholar
• van der Hoek W, Meekelenkamp JC, Leenders AC, Wijers N, Notermans DW, Hukkelhoven CW. Antibodies against Coxiella burnetii and pregnancy outcome during the 2007–2008 Q fever outbreaks in The Netherlands. BMC Infect. Dis. 11, 44 (2011).
   PubMed Web of Science ®Google Scholar
• Madariaga MG, Rezai K, Trenholme GM, Weinstein RA. Q fever: a biological weapon in your backyard. Lancet Infect. Dis. 3(11), 709–721 (2003).
   PubMed Web of Science ®Google Scholar
• Pittman PR, Norris SL, Coonan KM, McKee KT Jr. An assessment of health status among medical research volunteers who served in the Project Whitecoat program at Fort Detrick, Maryland. Mil. Med. 170(3), 183–187 (2005).
   PubMed Web of Science ®Google Scholar
• Omsland A, Beare PA, Hill J et al. Isolation from animal tissue and genetic transformation of Coxiella burnetii are facilitated by an improved axenic growth medium. Appl. Environ. Microbiol. 77(11), 3720–3725 (2011).
   PubMed Web of Science ®Google Scholar
• Rolain JM, Lambert F, Raoult D. Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline. Ann. NY Acad. Sci. 1063, 252–256 (2005).
   PubMed Web of Science ®Google Scholar
• Rouli L, Rolain JM, El Filali A, Robert C, Raoult D. Genome sequence of Coxiella burnetii 109, a doxycycline-resistant clinical isolate. J. Bacteriol. 194(24), 6939 (2012).
   PubMed Web of Science ®Google Scholar
• Brennan RE, Samuel JE. Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay. J. Clin. Microbiol. 41(5), 1869–1874 (2003).
   PubMed Web of Science ®Google Scholar
• Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A. Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin. Infect. Dis. 45(5), 548–555 (2007).
   PubMed Web of Science ®Google Scholar
• Angelakis E, Million M, D'Amato F et al. Q fever and pregnancy: disease, prevention, and strain specificity. Eur. J. Clin. Microbiol. Infect. Dis. 32(3), 361–368 (2013).
   PubMed Web of Science ®Google Scholar
• Yeaman MR, Mitscher LA, Baca OG. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob. Agents Chemother. 31(7), 1079–1084 (1987).
   PubMed Web of Science ®Google Scholar
• Lever MS, Bewley KR, Dowsett B, Lloyd G. In vitro susceptibility of Coxiella burnetii to azithromycin, doxycycline, ciprofloxacin and a range of newer fluoroquinolones. Int. J. Antimicrob. Agents 24(2), 194–196 (2004).
   PubMed Web of Science ®Google Scholar
• Gikas A, Spyridaki I, Scoulica E, Psaroulaki A, Tselentis Y. In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin. Antimicrob. Agents Chemother. 45(11), 3276–3278 (2001).
   PubMed Web of Science ®Google Scholar
• Gikas A, Spyridaki I, Psaroulaki A, Kofterithis D, Tselentis Y. In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. Antimicrob. Agents Chemother. 42(10), 2747–2748 (1998).
   PubMed Web of Science ®Google Scholar
• Raoult D, Yeaman MR, Baca OG. Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells. Antimicrob. Agents Chemother. 33(5), 621–623 (1989).
   PubMed Web of Science ®Google Scholar
• Rolain JM, Maurin M, Raoult D. Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii. Antimicrob. Agents Chemother. 45(1), 301–302 (2001).
   PubMed Web of Science ®Google Scholar
• Raoult D, Torres H, Drancourt M. Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii. Antimicrob. Agents Chemother. 35(10), 2070–2077 (1991).
   PubMed Web of Science ®Google Scholar
• Bental T, Fejgin M, Keysary A et al. Chronic Q fever of pregnancy presenting as Coxiella burnetii placentitis: successful outcome following therapy with erythromycin and rifampin. Clin. Infect. Dis. 21(5), 1318–1321 (1995).
   PubMed Web of Science ®Google Scholar
• Hellmeyer L, Schmitz-Ziegler G, Slenczka W, Schmidt S. [Q Fever in pregnancy: a case report and review of the literature]. Z. Geburtshilfe Neonatol. 206(5), 193–198 (2002).
   PubMed Web of Science ®Google Scholar
• Keysary A, Itzhaki A, Rubinstein E, Oron C, Keren G. The in-vitro anti-rickettsial activity of macrolides. J. Antimicrob. Chemother. 38(4), 727–731 (1996).
   PubMed Web of Science ®Google Scholar
• Perez-del-Molino A, Aguado JM, Riancho JA, Sampedro I, Matorras P, Gonzalez-Macias J. Erythromycin and the treatment of Coxiella burnetii pneumonia. J. Antimicrob. Chemother. 28(3), 455–459 (1991).
   PubMed Web of Science ®Google Scholar
• Anderson AD, Kruszon-Moran D, Loftis AD et al. Seroprevalence of Q fever in the United States, 2003–2004. Am. J. Trop. Med. Hyg. 81(4), 691–694 (2009).
   PubMed Web of Science ®Google Scholar
• Prabhu M, Nicholson WL, Roche AJ et al. Q fever, spotted fever group, and typhus group rickettsioses among hospitalized febrile patients in northern Tanzania. Clin. Infect. Dis. 53(4), e8–15 (2011).
   Web of Science ®Google Scholar
• Million M, Walter G, Thuny F, Habib G, Raoult D. Evolution from acute q Fever to endocarditis is associated with underlying valvulopathy and age and can be prevented by prolonged antibiotic treatment. Clin. Infect. Dis. 57(6), 836–844 (2013).
   PubMed Web of Science ®Google Scholar
• Kampschreur LM, Oosterheert JJ, Hoepelman AI et al. Prevalence of chronic Q fever in patients with a history of cardiac valve surgery in an area where Coxiella burnetii is epidemic. Clin. Vaccine immunol. 19(8), 1165–1169 (2012).
   PubMedGoogle Scholar